Refractive surgery when you are farsighted — why the plus-power route is not the minus-power route reversed
Clinical evidence researched September 2026 · Prices researched July 2026
Almost every page about laser eye surgery, including most of ours, is written for short-sighted people. That is not editorial laziness; it is the shape of the market. But a farsighted eye is not a short-sighted eye with the sign flipped, and three specific asymmetries decide what a plus prescription can realistically buy — the number in your hand is probably not the number a surgeon will treat, the laser has a lower dioptric ceiling because it has to work backwards, and the implantable-lens fallback that rescues difficult minus eyes may not exist for you at all. Each of those changes a booking decision, and the third one changes it most, because it is the one travellers assume away.
The number you are carrying is probably not the number they will treat
Start here, because everything downstream depends on it and it is the step most likely to have been skipped. In a farsighted eye your own focusing muscle can take up part of the prescription and hide it. That is the mechanism behind the sentence so many hyperopic twenty-somethings say in a consulting room — that their vision has always been fine — and it is also why a refraction measured while that muscle is working reads lower than the eye's real optical requirement.
The remedy is ordinary and slightly tedious: drops that temporarily switch the muscle off, and a second refraction taken while it is off. What that reveals has a name, latent hyperopia, and the literature does not treat looking for it as an unusual precaution. Routine post-cycloplegic refraction is described as worth considering for all hyperopic adults between roughly 16 and 40 — which is to say, most people who fly somewhere to have their eyes lasered — and comparative work notes that cycloplegia serves two purposes at once: revealing latent hyperopia, and preventing the overestimation of myopia in eyes that are not really as short-sighted as they measure.
There is then a working convention about when the difference matters. A gap of more than about 0.50 D between the manifest refraction and the cycloplegic one is the threshold at which the cycloplegic figure has to be brought into the surgical plan rather than noted and set aside. Below that, the two numbers are close enough to be treated as one.
Which of the two numbers gets treated is a real clinical disagreement, not a detail
This is worth spelling out because it is one of the commonest reasons two competent surgeons hand a farsighted patient two different plans, and patients usually read that divergence as one of them being wrong.
One described approach treats the full cycloplegic refraction under 40 and the manifest refraction over 40. The reasoning is developmental: a younger eye still has accommodation in reserve and will go on revealing hidden hyperopia as that reserve declines, so correcting only what is currently manifest leaves a known future error untreated. An older eye has largely already given up its hidden portion, so the manifest figure is closer to the truth. A second approach is narrower — take the cycloplegic figure into account only where it exceeds the manifest by more than about 0.50 D, and otherwise plan on what the patient actually presents with.
Both are defensible. They can also produce visibly different plans from one pair of eyes, and the difference tends to be in the direction of treating more rather than less. So the question to put to a centre is not the abstract one about which method is correct. It is: which figure are you planning to treat in my case, and what was the difference between my two measurements?
A plus-power ablation is not a minus-power ablation run backwards
To correct short sight a laser flattens the centre of the cornea, and removing tissue from the middle of a dome is a direct way to flatten it. To correct long sight the cornea has to become steeper in the centre — and a laser can only subtract. The way it achieves a steeper centre is therefore indirect: it removes an annulus of tissue in the periphery and leaves the centre standing proud relative to its surroundings.
Three consequences follow from that geometry, and they are the reason hyperopic treatment is bounded in a way myopic treatment is not.
The dioptric ceiling is lower. Published practice for hyperopic LASIK commonly describes an upper limit in the region of +5.00 D of spherical equivalent, with a maximum post-operative keratometry around 49.00 D — a limit on how steep a cornea can be made before its optics stop behaving. A separate argument from induced aberration puts a comparable practical ceiling nearer +7.00 D. Either way it is a far tighter range than the minus side of the same machines.
The treated diameter has to be larger. Because the correction is built out of a peripheral ring, a hyperopic profile needs more corneal real estate than a myopic one of the same dioptric size. Improved stability in hyperopic treatment is attributed to enhanced profiles on larger optical zones — around 6.7 mm in one description, and aspheric profiles planning a defined change in corneal asphericity are delivered on zones of 6.5 mm or more, centred near the corneal vertex rather than the pupil. A small cornea or a large pupil is therefore a more limiting finding for a plus eye than for a minus one.
Regression and retreatment are more likely. The way epithelium and stroma remodel around a newly steepened centre is described as producing higher refractive regression than is normally observed after myopic correction. The difficulties reported for hyperopic LASIK are consistent across sources: decentration, a high rate of retreatment, frequent residual refractive error, induced astigmatism and raised corneal aberration — spherical aberration in particular, which is the one most often felt as reduced crispness or night-time quality rather than as blurred letters on a chart. Most current systems induce a little under 0.1 µm of spherical aberration per dioptre treated, which is what makes the dioptric ceiling an optical argument and not only a mechanical one.
None of that is an argument against hyperopic laser surgery. It is an argument for reading the enhancement policy before you pay, because the traveller's version of "a high rate of retreatment" is not an inconvenience — it is a second flight. Our page on enhancement policy and aftercare sets out the questions; a plus prescription is the case where they earn their keep.
The fallback inverts, and this is the part travellers get wrong
For a short-sighted patient the decision tree has a well-worn escape route. If the cornea is too thin, or the prescription too high for the tissue available, the answer is a lens placed inside the eye that removes no corneal tissue at all. Every ICL page on this site is written around that logic, and it is sound — for myopia.
A farsighted patient should not assume the same route exists. The EVO and EVO+ platform that Chinese refractive centres advertise, and that we describe in detail elsewhere, carries a myopia indication: its United States approval is written for spherical equivalents from -3.0 D to -20.0 D, with or without astigmatism, in phakic eyes. A hyperopic phakic lens is a different device with a separate and much narrower history and availability, and STAAR's hyperopic model belongs to an earlier generation of the product line rather than to the EVO family.
So the inversion is this. For a difficult minus eye, the lens is the safety net under the laser. For a plus eye, the laser has a lower ceiling and the safety net may not be strung. That is not a reason for despair — it is a reason to establish availability before you buy a flight, because finding out on the day converts a treatment plan into a cancelled trip.
Hyperopic SMILE is real — the question is whether that machine has the module
This has changed recently enough that most consumer writing has not caught up, and it is a genuine option to ask about rather than a rumour.
Lenticule extraction for long sight now exists as an approved product: ZEISS describes the first lenticule-extraction treatment for hyperopia reaching European markets under CE approval, a hyperopia module for the VISUMAX 800 was announced for release from September 2024, and a treatment range reaching approximately +7 D is described for SMILE pro. Early clinical outcome work on hyperopic SMILE performed on the VISUMAX 800 has been published.
What that does not establish is whether the specific machine in the specific hospital you are considering runs the hyperopic software. A platform holding an approved module and a given installation having that module licensed, updated and in routine use are two different facts, and only the second one affects you. It is also worth noting that United States clearance for the VISUMAX 800 with SMILE pro was written for nearsightedness — so an FDA reference in marketing material is not evidence that your treatment is covered by it.
We keep a separate page on which Chinese centres run the VISUMAX 800 and what the platform actually changes. Read it for the installed base; then ask the hyperopia question on top of it, because the two do not travel together.
The four routes for a plus eye, and what decides each one
| Route | Where it applies to a plus eye | The question that decides it |
|---|---|---|
| Hyperopic LASIK | The most established laser option, bounded by the ceilings above — commonly described around +5.00 D SE with post-op K near 49.00 D, and an aberration-based practical limit nearer +7.00 D | Your cycloplegic sphere, corneal diameter and pupil size — a peripheral-ring ablation needs room |
| Hyperopic SMILE | CE-approved and available on VISUMAX 800 installations carrying the hyperopia module, described up to roughly +7 D | Whether this hospital's VISUMAX 800 runs the hyperopic module, and the surgeon's case count on it |
| Surface ablation (TransPRK) | Same steepening geometry without a flap; whether a hyperopic profile is offered is platform- and centre-specific | Ask directly whether a hyperopic profile is available on their platform — do not infer it from a myopic price list |
| Hyperopic phakic lens | Do not assume this exists at your centre. The EVO family is myopia-indicated; a hyperopic phakic lens is a separate, far less widely available device | Availability, model and case count — established before travel, in writing |
Ceilings and zone figures are published ranges and study descriptions, not eligibility criteria for your eyes. Candidacy for any of these is determined by the operating surgeon after the diagnostic workup. Lens-replacement surgery, where the eye's own lens is removed, is a different category and is outside this site's scope.
The same prescription is a different problem at 25, at 38 and at 48
Accommodation declines across adult life in everybody. A farsighted eye, though, has been spending some of that capacity merely to see clearly in the distance, so it has less in reserve for near work than an eye of the same age with no refractive error. That is the mechanism behind the characteristic hyperopic story: vision that seemed unremarkable for years and then deteriorated quite suddenly at near, usually somewhere in the late thirties.
It follows that correcting the distance error does not exempt you from presbyopia and does not give accommodation back. What it changes is where you start. Under about 30, the live issues are the cycloplegic number and the ceiling. Past the late thirties you are holding two conversations at once — a hyperopia one and a presbyopia one — and the options that deliberately trade a little distance crispness for usable near range become relevant earlier than they would for a short-sighted patient of the same age. We cover those on their own pages: refractive surgery in your 40s and PRESBYOND laser blended vision. Read them alongside this page rather than instead of it.
What it costs, and the line item that matters more for you than for a myope
Being farsighted does not put you on a different price list. The standard ranges we publish for China, researched July 2026 and quoted per patient for both eyes, are the ones that apply:
| Procedure | China, standard rate | Note for a plus prescription |
|---|---|---|
| LASIK | $1,200–1,800 | Hyperopic profiles are within the normal scope of the platforms; the constraint is dioptric, not commercial |
| SMILE | $2,200–2,900 | Only meaningful if the installation carries the hyperopia module — confirm before comparing prices |
| TransPRK | $1,000–1,500 | Confirm a hyperopic profile is offered on their platform |
| EVO ICL | $3,800–4,800 | This price is for a myopia-indicated lens. It is not a quotation for a hyperopic phakic lens and should not be read as one |
Standard rates researched July 2026 and consistent with the ranges published on our home page. Ranges move, hospitals price individually, and a quotation for your eyes can only be produced after a workup. See what LASIK costs in China and what EVO ICL costs in China for the full breakdowns.
The line item to interrogate, though, is not the headline. It is the enhancement. Given that hyperopic correction is reported to regress more and to be retreated more often, the difference between a centre that includes an enhancement inside a stated window and one that treats it as a fresh private procedure is worth more to a farsighted traveller than a few hundred dollars on the first operation. Ask for the window in months, the cost if you fall outside it, and — the one people forget — whether the records will be released in a form a surgeon in your own country can act on.
What this does to the trip
Two things, and only the first is a delay everybody can plan for.
Cycloplegia costs you part of a day. The drops blur near vision and leave the pupils dilated for hours, so the assessment day is not a day for reading contracts, working on a laptop or driving. That is trivial if it is expected and irritating if it is not. It also means an assessment that included a proper cycloplegic refraction looks longer than one that skipped it — which is the opposite of how efficiency usually reads.
An accommodative spasm is not a one-week plan. This is the case worth knowing about before you book anything. Where a young farsighted patient's focusing muscle is locked in sustained over-activity, the described management is to wear a higher plus correction for a period of months in order to relax the spasm, so that the true latent hyperopia can be measured at all. If that is your situation, the honest sequence is spectacles first and surgery afterwards, on a timescale measured in months rather than days — and no amount of scheduling compresses it, because what is being waited for is a measurement rather than a slot. It is a minority scenario. It is also one that nobody discovers without drops, which is the argument for taking the cycloplegic step seriously before you commit to travel dates. Our page on how long to stay in China assumes the ordinary case; this is the exception to it.
What to ask before you book, in the order that saves the most money
- Have I had a cycloplegic refraction, and what were both numbers? Manifest and cycloplegic, sphere and cylinder, each eye, in writing. If the answer is no, the rest of the list is premature.
- Which figure will the surgeon treat, and why? A clear answer is a good sign regardless of which convention they follow.
- Do you implant a hyperopic phakic lens — which model, how many? Ask even if you expect a laser, because it is the question that establishes whether a fallback exists.
- If SMILE is proposed: does your VISUMAX 800 run the hyperopic module? And how many hyperopic cases has this surgeon performed on it?
- What is the enhancement window, what does an enhancement cost outside it, and will I get my records? The plus-power case is where this matters.
- What optical zone is planned, and is my corneal diameter adequate for it? A peripheral-ring ablation needs room, and this is a question a surgeon can answer from your own topography.
If a centre quotes you a procedure and a price before the first item on that list exists, you have learned something useful about the centre. Nobody can responsibly name a procedure for a plus eye before the cycloplegic number is on the table — high hyperopia is one of the few areas of refractive surgery where the workup genuinely determines the operation rather than confirming a choice already made.
Questions people actually ask
Can you have LASIK if you are farsighted rather than nearsighted?
Yes, within a narrower range than most people expect, and the range is the whole answer. Hyperopic laser correction is an established treatment and it is not simply myopic treatment with the sign reversed. To correct a plus prescription the laser has to make the centre of the cornea steeper, and the only way a subtractive laser can steepen a centre is by removing a ring of tissue around it. That geometry sets a ceiling. Published practice for hyperopic LASIK commonly describes an upper limit around +5.00 D of spherical equivalent with a maximum post-operative keratometry near 49.00 D, and an aberration-based argument puts a comparable practical ceiling nearer +7.00 D. Above that, laser correction is generally not the route being discussed, and the conversation moves to lens-based options. So the useful question is not whether farsighted people can have laser surgery but what your cycloplegic number is, because that number decides which of these conversations you are in. Candidacy is determined by the operating surgeon after the full workup.
Why does a farsighted person need dilating drops before a refractive assessment?
Because in a plus eye your own focusing muscle hides part of your prescription, and the hidden part is surgically relevant. A hyperopic eye can mask some of its refractive error by accommodating, which is why many farsighted people in their twenties report that their vision has always been fine. A refraction taken while that muscle is active therefore reads lower than the eye's true optical requirement. Cycloplegic drops temporarily stop the muscle and reveal what is called latent hyperopia. The clinical literature treats this as routine rather than exceptional in exactly your age band, with post-cycloplegic refraction described as worth considering for all hyperopic adults between roughly 16 and 40, and studies note that cycloplegia both reveals latent hyperopia and prevents the overestimation of myopia. There is an ordinary working convention that a difference of more than about 0.50 D between the manifest and the cycloplegic refraction is the point at which the cycloplegic figure has to be taken into account in planning. The practical consequence for a traveller is simple: if the number in your hand came from a sight test without drops, treat it as provisional.
Which number will the surgeon actually treat — the one from my optician or the one from the drops?
This is a genuine point of clinical variation rather than a settled rule, which is precisely why you should ask instead of assuming. One widely described approach treats the full cycloplegic refraction in patients under 40 and the manifest refraction in patients over 40, on the reasoning that a younger eye will continue to reveal hidden hyperopia as accommodation declines while an older eye has largely already revealed it. Another approach takes the cycloplegic figure into account only where it differs from the manifest figure by more than about 0.50 D. Both are defensible and they can produce meaningfully different plans from the same pair of eyes. That matters more to you than to a myopic patient, because the gap between manifest and cycloplegic is where hyperopic surprises live, and it is the gap most likely to be behind two centres proposing different corrections. So the question to put to the centre is not which number is right in general but which number this surgeon plans to treat in your case and why. Ask for both figures in writing.
Is EVO ICL a fallback for farsightedness the way it is for thin corneas and high myopia?
Not in the way our own ICL pages might lead you to assume, and this is the single most important asymmetry on this page. For a myopic patient the logic is familiar: if the cornea is too thin or the prescription too high for tissue removal, the implantable lens is the route that does not touch the cornea. A hyperopic patient cannot assume the same fallback exists. STAAR's EVO and EVO+ platform — the lens family described throughout this site and the one Chinese centres advertise — carries a myopia indication, and its United States approval is written for spherical equivalents from -3.0 D to -20.0 D with or without astigmatism. A hyperopic phakic lens is a different product with a separate and far more limited history and availability. So the sentence to carry away is that the standard rescue path for a difficult minus eye may simply not be on the menu for a plus eye at a given centre. Do not infer availability from an ICL price list. Ask the centre directly, before booking, whether they implant a hyperopic phakic lens at all and which model.
Can SMILE treat hyperopia, and can it treat mine in China?
Those are two different questions and the second one is the one to ask the hospital. SMILE for hyperopia now exists as a real product rather than a research idea: ZEISS describes the first lenticule-extraction treatment for hyperopia reaching European markets under CE approval, a hyperopia module for the VISUMAX 800 was announced for release from September 2024, and a treatment range reaching up to about +7 D is described for SMILE pro. There is published early clinical outcome work on hyperopic SMILE on the VISUMAX 800. What none of that tells you is whether the particular machine in the particular hospital you are considering carries the hyperopia software, because a platform having an approved module and a given installation having it licensed and in use are not the same fact. This is a specific, checkable, non-negotiable pre-booking question, and it is the kind that separates a real answer from a brochure: does your VISUMAX 800 run the hyperopic SMILE module, and how many hyperopic cases has this surgeon done on it? Note also that United States clearance for the VISUMAX 800 with SMILE pro was written for nearsightedness, so do not read an FDA reference as covering your treatment.
Is hyperopic laser correction more likely to regress or need a second procedure?
The published picture says yes, and you should build that expectation into the money rather than into your hopes. The corneal response to a hyperopic ablation — where epithelium and stroma remodel around a steepened centre — is described as producing higher refractive regression than is usually seen after myopic correction, and reported difficulties with hyperopic LASIK include a high rate of retreatment, frequent residual refractive error and induced higher-order aberration, spherical aberration in particular. Modern profiles are aimed squarely at this: aspheric ablations planning a defined change in corneal asphericity, delivered on larger optical zones of roughly 6.5 mm or more centred near the corneal vertex, are the described mitigation, and most current systems induce somewhat under 0.1 µm of spherical aberration per dioptre treated. None of that makes an enhancement unlikely enough to ignore. The traveller-specific consequence is the one nobody writes down: an enhancement is a second appointment, and if you have flown home it is a second flight. Ask what the enhancement policy is, what it costs, how long the window lasts and whether a local surgeon can act on the records — before you pay for the first procedure.
Why do surgeons raise lens exchange for a young farsighted patient with a high prescription?
Because above the laser ceiling the remaining options are lens-based, and in a high plus eye the natural lens is one of the things a surgeon can act on. That conversation is legitimate and it carries a cost that is easy to miss when the discussion is framed around the prescription. Removing and replacing the eye's own lens with a standard monofocal implant ends accommodation permanently — the eye no longer changes focus on its own — and in a patient in their twenties or thirties that means trading a correctable optical error for a fixed focal distance and reading correction for life. That may still be the right trade for some people at some prescriptions, and it is emphatically not a decision to reach at the end of a consultation about laser surgery. It is also lens-replacement surgery rather than refractive corneal surgery, which is outside this site's scope; our sister property eyesurgerychina.com covers lens-based eye surgery in China. What belongs here is the warning: if a plan for your plus prescription moves from the cornea to the lens, the question that changed is not the price but whether you keep your own focusing ability.
Does being farsighted mean I will need reading glasses sooner after surgery?
The honest answer is that your reading position was always going to change with age and that hyperopia changes when you notice it, not whether. Accommodation declines through adult life in everyone. A farsighted eye has been spending some of that focusing capacity simply to see clearly at distance, so it has less spare capacity for near work than an emmetropic eye of the same age — which is why hyperopic people often report near difficulty earlier and more abruptly, sometimes described as vision that seemed fine and then did not. Correcting the distance error surgically does not restore accommodation and does not exempt you from presbyopia. What it changes is the starting point. If you are in your late thirties or beyond, the sensible framing is that you are having a presbyopia conversation and a hyperopia conversation at the same time, and the options that deliberately trade some distance crispness for near range — blended vision approaches among them — belong in it. We cover those separately, and the reason to raise them here is that a plus prescription makes them relevant earlier than a minus one does.
I have +8.50 and I am under 30. What is realistic?
Take that number as a starting point for a conversation rather than as a specification, for two reasons that pull in opposite directions. First, a figure that high sits above the ceilings described for hyperopic laser correction, so a straightforward LASIK, SMILE or surface-ablation plan is unlikely to be what a careful surgeon proposes. Second, your true figure is not yet established if it was measured without cycloplegia, and in a young plus eye the cycloplegic number is characteristically the higher of the two, so the measurement most likely to change the plan has not been taken. What follows is not a procedure recommendation, which nobody can responsibly give from a page: it is a sequence. Get a cycloplegic refraction and obtain both numbers in writing. Ask specifically whether the centre implants a hyperopic phakic lens, because the EVO family you have read about is indicated for myopia. Treat any lens-exchange proposal as a separate decision about accommodation rather than a variation on laser surgery. And be sceptical of a plan quoted before those numbers exist. High hyperopia is one of the few places where the workup genuinely determines the procedure rather than confirming it.